PEP-Therapy
-
2014
Company Description
PEP-Therapy, a Paris, France-based biotechnology company
PEP-Therapy SAS is a biotech company developing targeted therapies for the treatment of severe diseases, with an initial focus on cancer. PEP-Therapy develops Cell Penetrating and Interfering Peptides (CP&IP) for the intracellular delivery of targeted therapies. These active compounds penetrate cells and block relevant intracellular protein-protein interactions, thus inhibiting specifically key mechanisms of diseases.
-
Manufacturer:
Science and Engineering -
Formed:
2014 -
Founders:
Antoine Prestat -
Company Website:
-
Company E-mail:
-
Company Address:
France4 rue Pierre Fontaine Evry cedex -
CEO:
- Antoine Prestat
-
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits